Am J Ophthalmol:继发于沙眼衣原体和淋病奈瑟菌双重感染的成人结膜炎病例报告

2018-12-24 MedSci MedSci原创

英国布莱克浦维多利亚医院眼科和曼彻斯特皇家眼科医院的Linton E近日在Am J Ophthalmol杂志上发表了一篇重要的工作。沙眼衣原体和淋病奈瑟氏球菌在英格兰最常见的是性传播感染方式,而关于眼部感染的报道文献有限。他们报告了这样一个治疗反应良好的病例,并讨论了目前可用于治疗这些病例的文献和证据。

英国布莱克浦维多利亚医院眼科和曼彻斯特皇家眼科医院的Linton E近日在Am J Ophthalmol杂志上发表了一篇重要的工作。沙眼衣原体和淋病奈瑟氏球菌在英格兰最常见的是性传播感染方式,而关于眼部感染的报道文献有限。他们报告了这样一个治疗反应良好的病例,并讨论了目前可用于治疗这些病例的文献和证据。

患者是一名48岁的两性恋男性,其左眼出现红肿,经治疗出院后一周再次出现视力模糊。最初诊断时,他有粘液状的脓性分泌物,但他的角膜很清楚。但他不遵守处方治疗方案,两天后患者因为双侧症状复发和左眼角膜变薄等原因返回医院治疗。经检查,沙眼衣原体和淋病奈瑟菌的PCR检测为阳性,因此对患者开始进行静脉注射头孢曲松,口服和外用左氧氟沙星滴眼液。在住院治疗48小时后,患者的临床症状得到改善。

因此,作者建议,眼科医生应该意识到沙眼衣原体和淋病奈瑟菌可能引起成人结膜炎的共同感染,可以据此对个体开展相应治疗方法。受病菌感染影响的患者,如果出现延迟诊断和治疗则可能导致角膜并发症和失明的风险。同时,作者建议尽可能与当地的微生物学服务部门讨论这些案例,以便更好的进行治疗。

原文出处:

Linton, E., et al., Adult conjunctivitis secondary to dual infection with Chlamydia trachomatis and Neisseria gonorrhoeae - A case report. Am J Ophthalmol Case Rep, 2019. 13: p. 6-8.

本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
    2019-11-18 feifers
  2. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
    2018-12-26 chenshujs
  8. [GetPortalCommentsPageByObjectIdResponse(id=1724482, encodeId=89ad1e2448258, content=<a href='/topic/show?id=78ece8958b2' target=_blank style='color:#2F92EE;'>#继发#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78958, encryptionId=78ece8958b2, topicName=继发)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=499d33645837, createdName=feifers, createdTime=Mon Nov 18 07:10:00 CST 2019, time=2019-11-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677499, encodeId=1c9616e7499b6, content=<a href='/topic/show?id=2ebbe881920' target=_blank style='color:#2F92EE;'>#结膜炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78819, encryptionId=2ebbe881920, topicName=结膜炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=803827523485, createdName=tm10051990, createdTime=Mon Dec 31 02:10:00 CST 2018, time=2018-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1377016, encodeId=e6f413e701627, content=<a href='/topic/show?id=8ff8e0777c5' target=_blank style='color:#2F92EE;'>#病例报告#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70777, encryptionId=8ff8e0777c5, topicName=病例报告)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8143398, createdName=lily1616, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1476239, encodeId=c8f014e62393a, content=<a href='/topic/show?id=b43c6448366' target=_blank style='color:#2F92EE;'>#沙眼衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=45, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64483, encryptionId=b43c6448366, topicName=沙眼衣原体)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=48057256841, createdName=liuyg0230, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1528176, encodeId=71a515281e6b9, content=<a href='/topic/show?id=942190103af' target=_blank style='color:#2F92EE;'>#衣原体#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90103, encryptionId=942190103af, topicName=衣原体)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=744011903191, createdName=wushaoling, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1541422, encodeId=5de715414220f, content=<a href='/topic/show?id=5c961e37307' target=_blank style='color:#2F92EE;'>#THA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=41, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=17373, encryptionId=5c961e37307, topicName=THA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=615b13300589, createdName=1249842em13(暂无昵称), createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1560475, encodeId=203515604e579, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1566484, encodeId=75bb1566484d4, content=<a href='/topic/show?id=a472644828c' target=_blank style='color:#2F92EE;'>#沙眼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=64482, encryptionId=a472644828c, topicName=沙眼)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2c5615156509, createdName=chenshujs, createdTime=Wed Dec 26 13:10:00 CST 2018, time=2018-12-26, status=1, ipAttribution=)]
    2018-12-26 chenshujs

相关资讯

Am J Obstet Gynecol:青少年和年轻妇女HPV、沙眼衣原体共同感染的流行病学调查

背景:人乳头瘤病毒(HPV)、沙眼衣原体(CT)共享相同的性传输路线,并具有相同的危险因素,提示合并感染可能对上皮细胞异常的诱导起协同作用。目的:本研究的目的是确定在青少年和年轻女性中的HPV和CT的患病率,并确定与共同感染的因素。方法:本研究包括276名性活跃参与者,年龄在15-24岁。进行了采访、宫颈标本收集行宫颈涂片和分子试验。对所有宫颈标本测试27个HPV基因型,当然通过PCR也对CT进行

Nat Gene:沙眼衣原体全基因组序列公布

3月份出版的《自然—遗传学》刊登了剑桥大学研究人员的的一份报告,该论文公布了沙眼衣原体的全基因组序列。沙眼衣原体是一种人体病原体,除了能引发沙眼这种可致盲疾病,还能引发性传播流行疾病。 Simon Harris和同事对53种沙眼衣原体进行了全基因组测序和对比。为保证临床标本的多样化,他们从1959年至2009年间发生的多种流行病中挑选出了这些病原体。利用测序数据,他们为该病原体建立了一套更精